Related Experiment Videos

Molecular cloning of canine RCAS1 cDNA

Yasuhiko Okamura1, Zhiyong Ma, Tanvir S Khatlani

  • 1Faculty of Agriculture, Yamaguchi University, Yoshida, Yamaguchi, Japan.

Insights

Researchers identified canine Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) from mammary tumors. This novel cancer antigen is highly conserved across species and inhibits immune cell growth, inducing apoptosis.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is a novel cancer cell-surface antigen.
  • RCAS1 is strongly expressed in invasive cancers and inhibits immunocyte growth, inducing apoptosis.

Purpose of the Study:

  • To clone and identify canine RCAS1 cDNA.
  • To analyze the structural and functional conservation of canine RCAS1.

Main Methods:

  • Cloning of canine RCAS1 cDNA from a mammary gland tumor.
  • Sequence analysis of canine RCAS1 cDNA and protein.

Main Results:

  • Canine RCAS1 cDNA is 864 bp with a 642 bp open reading frame encoding 213 amino acids.
  • Canine RCAS1 protein shares 96.2% and 96.7% homology with human and mouse RCAS1, respectively.
  • Key structural features, including a transmembrane segment and coiled-coil structure, are conserved.

Conclusions:

  • Canine RCAS1 is a highly conserved protein with functional similarities to human and mouse RCAS1.
  • The identification of canine RCAS1 provides a valuable model for studying cancer immunology and antigen function.

Related Concept Videos